# Rosiglitazone and Insulin Resistance in Renally Impaired Patients

> **NCT00452166** · PHASE3 · TERMINATED · sponsor: **Leiden University Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Chronic Kidney Disease
- Insulin Resistance

## Interventions

- **DRUG:** rosiglitazone

## Key facts

- **NCT ID:** NCT00452166
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-04
- **Primary completion:** 2008-03
- **Final completion:** 2008-05
- **Target enrollment:** 30 (ESTIMATED)
- **Why stopped:** it was not possible to recruit new patients anymore
- **Last updated:** 2008-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00452166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00452166, "Rosiglitazone and Insulin Resistance in Renally Impaired Patients". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00452166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*